-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $5.5

Benzinga·11/06/2026 00:20:57
Listen to the news
UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and raises the price target from $5 to $5.5.